ARAV : Insider Transactions for Aravive Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Aravive Inc (ARAV)

$0.04 0.00 (0.00%) as of 4:30 Fri 1/26

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

19,370,000

Market Cap:

776.74(K)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.0401 - $1.8

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Aravive is a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of diseases, including cancer and fibrosis. Co.'s primary product candidate, batiraxcept, is a decoy protein that targets the GAS6-AXL signaling pathway. By capturing serum GAS6, batiraxcept starves the AXL pathway of its signal, potentially halting the biological programming that promotes disease progression. AXL receptor signaling plays a role in multiple types of malignancies by promoting metastasis, cancer cell survival, resistance to treatments, and immune suppression.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 258

Page 5 of 11

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Akkaraju Srinivas

Director

– • –

2017-03-24

4

B

$12.25

$7,000,005

I/I

571,429

571,429

2.1

-

Chief Commercial Officer

• – –

2017-03-22

4

A

$0.00

$0

D/D

45,000

45,000

-

Director

– • –

2017-03-17

4

S

$18.01

$6,958,470

I/I

(386,367)

1,621,558

-

Director

– • –

2017-03-16

4

S

$18.50

$1,800,106

I/I

(97,303)

2,007,925

-

Director

– • –

2017-03-15

4

S

$19.08

$1,967,568

I/I

(103,122)

2,105,228

-

SVP and General Counsel

• – –

2017-03-15

4

S

$19.02

$14,760

D/D

(776)

36,350

-

Director

– • –

2017-03-14

4

S

$19.00

$890,685

I/I

(46,878)

2,208,350

-

SVP and General Counsel

• – –

2017-03-14

4

S

$19.00

$24,035

D/D

(1,265)

37,126

-

Director

– • –

2017-03-13

4

S

$19.42

$317,129

I/I

(16,330)

2,255,228

-

SVP and Chief Business Officer

• – –

2017-02-27

4

AS

$22.50

$281,250

D/D

(12,500)

69,544

-

SVP and Chief Business Officer

• – –

2017-02-27

4

OE

$1.61

$24,717

D/D

12,500

82,044

-

President and CEO

• • –

2017-02-27

4

AS

$24.00

$123,984

D/D

(5,166)

213,858

-

President and CEO

• • –

2017-02-27

4

OE

$2.53

$13,070

D/D

5,166

219,024

-

COO and CFO

• – –

2017-02-24

4

AS

$20.42

$628,063

D/D

(30,000)

105,779

-

COO and CFO

• – –

2017-02-24

4

OE

$2.53

$75,900

D/D

30,000

135,779

-

SVP and Chief Business Officer

• – –

2017-02-23

4

AS

$20.00

$131,800

D/D

(6,590)

69,544

-

SVP and Chief Business Officer

• – –

2017-02-23

4

OE

$1.61

$10,610

D/D

6,590

76,134

-

President and CEO

• • –

2017-02-23

4

AS

$20.00

$160,000

D/D

(8,000)

213,858

-

President and CEO

• • –

2017-02-23

4

OE

$2.53

$20,240

D/D

8,000

221,858

-

SVP and Chief Business Officer

• – –

2017-02-21

4

AS

$17.50

$336,950

D/D

(18,410)

69,544

-

SVP and Chief Business Officer

• – –

2017-02-21

4

OE

$1.61

$29,640

D/D

18,410

87,954

-

President and CEO

• • –

2017-02-21

4

AS

$18.50

$148,000

D/D

(8,000)

213,858

-

President and CEO

• • –

2017-02-21

4

OE

$2.53

$20,240

D/D

8,000

221,858

-

Perceptive Life Sciences Master Fund Ltd

10% Owner

– – •

2017-02-13

4

B

$15.51

$917,425

I/I

59,133

4,228,563

1.5

-

Perceptive Life Sciences Master Fund Ltd

10% Owner

– – •

2017-02-10

4

B

$14.94

$521,281

I/I

34,883

4,169,430

1.5

-

258 Records found	1 2 3 4 5 6 7 8 9 Next	Page 5 of 11

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.